Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
Top Cited Papers
Open Access
- 13 March 2008
- journal article
- review article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 22 (4), 686-707
- https://doi.org/10.1038/leu.2008.26
Abstract
Mutations and chromosomal translocations occur in leukemic cells that result in elevated expression or constitutive activation of various growth factor receptors and downstream kinases. The Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways are often activated by mutations in upstream genes. The Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways are regulated by upstream Ras that is frequently mutated in human cancer. Recently, it has been observed that the FLT-3 and Jak kinases and the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) phosphatase are also frequently mutated or their expression is altered in certain hematopoietic neoplasms. Many of the events elicited by the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways have direct effects on survival pathways. Aberrant regulation of the survival pathways can contribute to uncontrolled cell growth and lead to leukemia. In this review, we describe the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT signaling cascades and summarize recent data regarding the regulation and mutation status of these pathways and their involvement in leukemia.Keywords
This publication has 345 references indexed in Scilit:
- A transforming mutation in the pleckstrin homology domain of AKT1 in cancerNature, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Ubiquitination Regulates PTEN Nuclear Import and Tumor SuppressionCell, 2007
- Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2006
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPKNature, 2003
- Rheb is a direct target of the tuberous sclerosis tumour suppressor proteinsNature, 2003
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- Mutations of the BRAF gene in human cancerNature, 2002
- Phosphatidylinositol-3-OH kinase direct target of RasNature, 1994